HMGN2P46 is a pseudogene that is strongly expressed in AR-expressing prostate cancers but not expressed in AR-negative cancers in our cohort, suggesting an androgen regulated promoter. The gene discussed is HMGN2P46; the disease is prostate carcinoma.